IMCR vs NCLH · rev $222.6M vs P/E 16, rev $4.97B
Immunocore Holdings Ltd (IMCR) versus Norwegian Cruise Line Holdings Ltd (NCLH) — a side-by-side from cached financials, not a winner call.
Immunocore Holdings Ltd (IMCR) is a biotechnology company listed on NASDAQ.
Norwegian Cruise Line Holdings Ltd (NCLH) is a travel services company listed on NYSE.
Latest reported IMCR revenue for 2026-06-30 was $222.6M. Net income was $12.2M. IMCR currently screens at market cap $1.45B.
Latest reported NCLH revenue for 2026-06-30 was $4.97B. Net income was $327.2M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
IMCR currently screens at market cap $1.45B. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
Not investment advice. Open the IMCR and NCLH stock pages for the full models.
Not investment advice.